Clinical trial
A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft as an Above-Knee Femoro-Popliteal Bypass Graft in Patients With Peripheral Arterial Disease
NCT01872208 is registered in ClinicalTrials.gov with Humacyte, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft as an Above-Knee Femoro-Popliteal Bypass Graft in Patients With Peripheral Arterial Disease
- Lead sponsor
- Humacyte, Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 10, 2013
- Completion date
- July 18, 2024
- Enrollment
- 20 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
peripheral arterial disease, peripheral vascular disease